| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |